Doxorubicin Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Drug Formulation ( lyophilized powder, doxorubicin injection ); Type of Cancer ( lung cancer, Hodgkin's and non-Hodgkin's cancer, breast cancer, prostate cancer, ovary cancer, stomach cancer, leukemia, others ); Distribution Channel ( hospital pharmacy, retail pharmacy, online pharmacy )

Report Code: TIPRE00011780 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Doxorubicin is the generic drug that is for anti-cancer chemotherapy drug Adriamycin and Rubex. However, doxorubicin is an anthracycline antibiotic and belongs to the group of anti-cancer medication known as antineoplastic and is made from the natural product produced. It is used for the treatment of different types of cancer, also breast, stomach, ovary, bone, testicles, bladder, lung, soft tissue, osteogenic sarcoma, Wilms' tumor, and Hodgkin's and non-Hodgkin's lymphomas. It is also used less commonly in the treatment of squamous cell carcinomas of the head and neck. Vagina and cervix, multiple refractory myeloma, and neuroblastoma. Doxorubicin inhibits and or slows the rate of proliferation of cancerous cells by intercalating between the base pairs in the DNA helix, thereby preventing DNA replication and inhibiting protein synthesis. Also, this medication is available in injection solution and lyophilized powder form and is administered intravenously either through peripheral inserted central line catheters (PICC) or central venous catheters (CVC).

MARKET DYNAMICS

The doxorubicin market is owing to increasing prevalence of cancer patients worldwide. Moreover, it can cause side effects such as nausea, vomiting, diarrhea, loss of appetite, and reddish urine after one to two days of treatment boost the growth of the market for doxorubicin.

MARKET SCOPE

The "Doxorubicin Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of doxorubicin market with detailed market segmentation by drug formulation, type of drug and distribution channel. The doxorubicin market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in doxorubicin market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The doxorubicin market is segmented on the basis of drug formulation, type of drug and distribution channel Based on drug formulation, the market is segmented as lyophilized powder and doxorubicin injection. On the basis of type of cancer, the market is categorized as lung cancer, Hodgkin's and non-Hodgkin's cancer, breast cancer, prostate cancer, ovary cancer, stomach cancer, leukemia, and others. On the basis of distribution channel, the market is categorized as hospital pharmacy, retail pharmacy, and online pharmacy.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the doxorubicin market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The doxorubicin market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting doxorubicin market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the doxorubicin market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the doxorubicin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from doxorubicin market are anticipated to have lucrative growth opportunities in the future with the rising demand for doxorubicin in the global market. Below mentioned is the list of few companies engaged in the doxorubicin market.

The report also includes the profiles of key players in doxorubicin market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Accord Healthcare
  •   Allergan, Inc.
  •   Dr. Reddy's Laboratories Ltd.
  •   Johnson & Johnson
  •   Meiji Seika Pharma Co.
  •   Merrimack Pharmaceuticals, Inc.
  •   Novartis AG
  •   Pfizer, Inc.
  •   Sun Pharmaceutical Industries Ltd.
  •   Thymoorgan Pharmazie GmbH


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Doxorubicin Market - By Drug Formulation
1.3.2 Doxorubicin Market - By Type of Cancer
1.3.3 Doxorubicin Market - By Distribution Channel
1.3.4 Doxorubicin Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DOXORUBICIN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DOXORUBICIN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DOXORUBICIN MARKET - GLOBAL MARKET ANALYSIS
6.1. DOXORUBICIN - GLOBAL MARKET OVERVIEW
6.2. DOXORUBICIN - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. DOXORUBICIN MARKET - REVENUE AND FORECASTS TO 2028 - DRUG FORMULATION
7.1. OVERVIEW
7.2. DRUG FORMULATION MARKET FORECASTS AND ANALYSIS
7.3. LYOPHILIZED POWDER
7.3.1. Overview
7.3.2. lyophilized powder Market Forecast and Analysis
7.4. DOXORUBICIN INJECTION
7.4.1. Overview
7.4.2. doxorubicin injection Market Forecast and Analysis
8. DOXORUBICIN MARKET - REVENUE AND FORECASTS TO 2028 - TYPE OF CANCER
8.1. OVERVIEW
8.2. TYPE OF CANCER MARKET FORECASTS AND ANALYSIS
8.3. LUNG CANCER
8.3.1. Overview
8.3.2. lung cancer Market Forecast and Analysis
8.4. HODGKIN'S AND NON-HODGKIN'S CANCER
8.4.1. Overview
8.4.2. Hodgkin's and non-Hodgkin's cancer Market Forecast and Analysis
8.5. BREAST CANCER
8.5.1. Overview
8.5.2. breast cancer Market Forecast and Analysis
8.6. PROSTATE CANCER
8.6.1. Overview
8.6.2. prostate cancer Market Forecast and Analysis
8.7. OVARY CANCER
8.7.1. Overview
8.7.2. ovary cancer Market Forecast and Analysis
8.8. STOMACH CANCER
8.8.1. Overview
8.8.2. stomach cancer Market Forecast and Analysis
8.9. LEUKEMIA
8.9.1. Overview
8.9.2. leukemia Market Forecast and Analysis
8.10. OTHERS
8.10.1. Overview
8.10.2. others Market Forecast and Analysis
9. DOXORUBICIN MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACY
9.3.1. Overview
9.3.2. hospital pharmacy Market Forecast and Analysis
9.4. RETAIL PHARMACY
9.4.1. Overview
9.4.2. retail pharmacy Market Forecast and Analysis
9.5. ONLINE PHARMACY
9.5.1. Overview
9.5.2. online pharmacy Market Forecast and Analysis
10. DOXORUBICIN MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Doxorubicin Market Overview
10.1.2 North America Doxorubicin Market Forecasts and Analysis
10.1.3 North America Doxorubicin Market Forecasts and Analysis - By Drug Formulation
10.1.4 North America Doxorubicin Market Forecasts and Analysis - By Type of Cancer
10.1.5 North America Doxorubicin Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Doxorubicin Market Forecasts and Analysis - By Countries
10.1.6.1 United States Doxorubicin Market
10.1.6.1.1 United States Doxorubicin Market by Drug Formulation
10.1.6.1.2 United States Doxorubicin Market by Type of Cancer
10.1.6.1.3 United States Doxorubicin Market by Distribution Channel
10.1.6.2 Canada Doxorubicin Market
10.1.6.2.1 Canada Doxorubicin Market by Drug Formulation
10.1.6.2.2 Canada Doxorubicin Market by Type of Cancer
10.1.6.2.3 Canada Doxorubicin Market by Distribution Channel
10.1.6.3 Mexico Doxorubicin Market
10.1.6.3.1 Mexico Doxorubicin Market by Drug Formulation
10.1.6.3.2 Mexico Doxorubicin Market by Type of Cancer
10.1.6.3.3 Mexico Doxorubicin Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Doxorubicin Market Overview
10.2.2 Europe Doxorubicin Market Forecasts and Analysis
10.2.3 Europe Doxorubicin Market Forecasts and Analysis - By Drug Formulation
10.2.4 Europe Doxorubicin Market Forecasts and Analysis - By Type of Cancer
10.2.5 Europe Doxorubicin Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Doxorubicin Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Doxorubicin Market
10.2.6.1.1 Germany Doxorubicin Market by Drug Formulation
10.2.6.1.2 Germany Doxorubicin Market by Type of Cancer
10.2.6.1.3 Germany Doxorubicin Market by Distribution Channel
10.2.6.2 France Doxorubicin Market
10.2.6.2.1 France Doxorubicin Market by Drug Formulation
10.2.6.2.2 France Doxorubicin Market by Type of Cancer
10.2.6.2.3 France Doxorubicin Market by Distribution Channel
10.2.6.3 Italy Doxorubicin Market
10.2.6.3.1 Italy Doxorubicin Market by Drug Formulation
10.2.6.3.2 Italy Doxorubicin Market by Type of Cancer
10.2.6.3.3 Italy Doxorubicin Market by Distribution Channel
10.2.6.4 Spain Doxorubicin Market
10.2.6.4.1 Spain Doxorubicin Market by Drug Formulation
10.2.6.4.2 Spain Doxorubicin Market by Type of Cancer
10.2.6.4.3 Spain Doxorubicin Market by Distribution Channel
10.2.6.5 United Kingdom Doxorubicin Market
10.2.6.5.1 United Kingdom Doxorubicin Market by Drug Formulation
10.2.6.5.2 United Kingdom Doxorubicin Market by Type of Cancer
10.2.6.5.3 United Kingdom Doxorubicin Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Doxorubicin Market Overview
10.3.2 Asia-Pacific Doxorubicin Market Forecasts and Analysis
10.3.3 Asia-Pacific Doxorubicin Market Forecasts and Analysis - By Drug Formulation
10.3.4 Asia-Pacific Doxorubicin Market Forecasts and Analysis - By Type of Cancer
10.3.5 Asia-Pacific Doxorubicin Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Doxorubicin Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Doxorubicin Market
10.3.6.1.1 Australia Doxorubicin Market by Drug Formulation
10.3.6.1.2 Australia Doxorubicin Market by Type of Cancer
10.3.6.1.3 Australia Doxorubicin Market by Distribution Channel
10.3.6.2 China Doxorubicin Market
10.3.6.2.1 China Doxorubicin Market by Drug Formulation
10.3.6.2.2 China Doxorubicin Market by Type of Cancer
10.3.6.2.3 China Doxorubicin Market by Distribution Channel
10.3.6.3 India Doxorubicin Market
10.3.6.3.1 India Doxorubicin Market by Drug Formulation
10.3.6.3.2 India Doxorubicin Market by Type of Cancer
10.3.6.3.3 India Doxorubicin Market by Distribution Channel
10.3.6.4 Japan Doxorubicin Market
10.3.6.4.1 Japan Doxorubicin Market by Drug Formulation
10.3.6.4.2 Japan Doxorubicin Market by Type of Cancer
10.3.6.4.3 Japan Doxorubicin Market by Distribution Channel
10.3.6.5 South Korea Doxorubicin Market
10.3.6.5.1 South Korea Doxorubicin Market by Drug Formulation
10.3.6.5.2 South Korea Doxorubicin Market by Type of Cancer
10.3.6.5.3 South Korea Doxorubicin Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Doxorubicin Market Overview
10.4.2 Middle East and Africa Doxorubicin Market Forecasts and Analysis
10.4.3 Middle East and Africa Doxorubicin Market Forecasts and Analysis - By Drug Formulation
10.4.4 Middle East and Africa Doxorubicin Market Forecasts and Analysis - By Type of Cancer
10.4.5 Middle East and Africa Doxorubicin Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Doxorubicin Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Doxorubicin Market
10.4.6.1.1 South Africa Doxorubicin Market by Drug Formulation
10.4.6.1.2 South Africa Doxorubicin Market by Type of Cancer
10.4.6.1.3 South Africa Doxorubicin Market by Distribution Channel
10.4.6.2 Saudi Arabia Doxorubicin Market
10.4.6.2.1 Saudi Arabia Doxorubicin Market by Drug Formulation
10.4.6.2.2 Saudi Arabia Doxorubicin Market by Type of Cancer
10.4.6.2.3 Saudi Arabia Doxorubicin Market by Distribution Channel
10.4.6.3 U.A.E Doxorubicin Market
10.4.6.3.1 U.A.E Doxorubicin Market by Drug Formulation
10.4.6.3.2 U.A.E Doxorubicin Market by Type of Cancer
10.4.6.3.3 U.A.E Doxorubicin Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Doxorubicin Market Overview
10.5.2 South and Central America Doxorubicin Market Forecasts and Analysis
10.5.3 South and Central America Doxorubicin Market Forecasts and Analysis - By Drug Formulation
10.5.4 South and Central America Doxorubicin Market Forecasts and Analysis - By Type of Cancer
10.5.5 South and Central America Doxorubicin Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Doxorubicin Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Doxorubicin Market
10.5.6.1.1 Brazil Doxorubicin Market by Drug Formulation
10.5.6.1.2 Brazil Doxorubicin Market by Type of Cancer
10.5.6.1.3 Brazil Doxorubicin Market by Distribution Channel
10.5.6.2 Argentina Doxorubicin Market
10.5.6.2.1 Argentina Doxorubicin Market by Drug Formulation
10.5.6.2.2 Argentina Doxorubicin Market by Type of Cancer
10.5.6.2.3 Argentina Doxorubicin Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL DOXORUBICIN MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. DOXORUBICIN MARKET, KEY COMPANY PROFILES
13.1. ACCORD HEALTHCARE
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ALLERGAN, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. DR. REDDY'S LABORATORIES LTD.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. JOHNSON AND JOHNSON
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. MEIJI SEIKA PHARMA CO.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. MERRIMACK PHARMACEUTICALS, INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. NOVARTIS AG
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. PFIZER, INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SUN PHARMACEUTICAL INDUSTRIES LTD.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. THYMOORGAN PHARMAZIE GMBH
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Accord Healthcare
2. Allergan, Inc.
3. Dr. Reddy's Laboratories Ltd.
4. Johnson & Johnson
5. Meiji Seika Pharma Co.
6. Merrimack Pharmaceuticals, Inc.
7. Novartis AG
8. Pfizer, Inc.
9. Sun Pharmaceutical Industries Ltd.
10. Thymoorgan Pharmazie GmbH
TIPRE00011780
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking